Registry of MIUS for Urolithiasis (ReMIUS-U)

NCT06394908 | Enrolling By Invitation DMC

• 1 other identifier: MIUS.2022.001
• Study Type: observational
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this registry is to collect data on patients who have undergone minimally invasive treatments for urinary system stone disease, including percutaneous nephrolithotomy (PCNL), shock wave lithotripsy (SWL), semi-rigid ureterorenoscopy (URS), and flexible ureterorenoscopy (F-URS).

Conditions

Urolithiasis; Stone, Kidney; Stone Ureter; Complication of Surgical Procedure

Keywords

Prospective studies; Registries; Urolithiasis

Outcome Measures

Primary Outcomes (6)

• Operative durations of each treatment technique (PCNL, SWL, URS, F-URS)

  The duration of the operation time

  Operation/procedure day

• Operative radiation dosage of each treatment technique (PCNL, SWL, URS, F-URS)

  X-ray dosage

  Operation/procedure day

• Operative results of each treatment technique (PCNL, SWL, URS, F-URS)

  The duration of the laser time

  Operation/procedure day

• Postoperative results

  Postoperative estimated glomerular filtration rate (CKD Epidemiology Collaboration (CKD-EPI) equation) (mL/min/1.73 m2)

  immediately after procedure

• Rate of postoperative complication

  Abnormal clinical and laboratory findings that may be seen after surgery and require additional intervention, treatment, or follow-up

  up to 3 months, postoperatively

• Follow-up

  Follow-up results of patients for recurrence of disease of residual stones, if any reoperation records.

  up to 10 years

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who receive urolithiasis treatment without contraindication

You may qualify if:

• To have a medical indication for urolithiasis
• Complete data of treatment and follow-up course
• Patients with consent
• Patients \> 18 years-old
• Patients \< 18 years-old

You may not qualify if:

• Missing data
• Patients without consent
• Not to have a medical indication for urolithiasis treatment
• To have a contraindication for urolithiasis treatment

Sponsors & Collaborators

• Marmara University: lead
• Samsun Education and Research Hospital: collaborator
• Gazi University: collaborator
• Koç University: collaborator
• Baskent University: collaborator
• Cukurova University: collaborator
• Ondokuz Mayıs University: collaborator
• Muğla Sıtkı Koçman University: collaborator
• Necmettin Erbakan University: collaborator
• Alanya Alaaddin Keykubat University: collaborator
• Dokuz Eylul University: collaborator
• Hitit University: collaborator

Study Sites (1)

Marmara University Hospital

Istanbul, 34890, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Urolithiasis; Kidney Calculi; Ureterolithiasis

Condition Hierarchy (Ancestors)

Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Nephrolithiasis; Kidney Diseases; Urinary Calculi; Calculi; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms; Ureteral Diseases

Study Officials

• yiloren tanidir, Assoc.Prof

  Marmara University

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 10 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate professor

Study Record Dates

• First Submitted: April 18, 2024
• First Posted: May 1, 2024
• Study Start: May 10, 2023
• Primary Completion (Estimated): May 1, 2030
• Study Completion (Estimated): May 1, 2030
• Last Updated: August 20, 2025

Record last verified: 2025-08

Locations

TU (1)